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Gene-Specific Targeting of H3K9 Methylation
Is Sufficient for Initiating Repression In Vivo
us to use an endogenous chromosomal gene as a tran-
scriptional reporter system. All three constructs, G9A
and both SUV39H1 deletion 76 and deletion 149 (re-
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Point Richmond Tech Center ferred to throughout as Suv Del 76 or Suv Del 149)
constructs, employed in this study contain the minimal501 Canal Boulevard
Suite A100 catalytically active portions of the proteins [6, 14] (shown
schematically in Figure 1A). Chimeras of ZFP-A withRichmond, California 94804
either G9A or the two SUV39H1 deletions were all able to
efficiently repress the amount of VEGF-A protein (Figure
1B) and mRNA (not shown) produced by the endoge-Summary
nous VEGF-A locus 2- and 3-fold, respectively, de-
spite background VEGF-A gene expression from non-Covalent modifications of chromatin have emerged
transfected cells. Fusion of an alternative repressionas key determinants of the genome’s transcriptional
domain encoding the LBD of v-ErbA, a viral relative ofcompetence [1–3]. Histone H3 lysine 9 (H3K9) methyla-
avian thyroid hormone receptor protein and a knowntion is an epigenetic signal that is recognized by HP1
HDAC3/NCoR recruitment domain, to ZFP-A led to a[4, 5] and correlates with gene silencing in a variety of
similar decrease in transcription from this locus (Figureorganisms [3]. Discovery of the enzymes that catalyze
1B). Furthermore, use of a ZFP that targets these do-H3K9 methylation [6–8] has identified a second gene-
mains to the IGF2 and H19 genes led to the concomitantspecific function for this modification in transcriptional
transcriptional repression of these specific targets,repression [9–11]. Whether H3K9 methylation is caus-
demonstrating the generality of this effect (data notative in the initiation and establishment of gene repres-
shown). No repression was observed when HEK293 cellssion or is a byproduct of the process leading to the
were transfected with a plasmid expressing v-ErbA LBDrepressed state remains unknown. To investigate the
fused to GFP, nor with cells transfected with controlrole of HMTs and specifically H3K9 methylation in gene
plasmids (PCDNA3.1 and GFP). Thus, direct recruitmentrepression, we have employed engineered zinc-finger
of HMT domains results in the transcriptional repressiontranscription factors (ZFPs) to target HMT activity to
of the targeted gene in vivo. Interestingly, however, nei-a specific endogenous gene. By utilizing ZFPs that
ther G9A, SUV39H1, nor v-ErbA ZFP fusion proteinsrecognize the promoter of the endogenous VEGF-A
were able to effectively repress a transiently transfectedgene [12], and thus employing this chromosomal locus
luciferase reporter plasmid containing the VEGF-A geneas an in vivo reporter, we show that ZFPs linked to a
promoter (Figure 1C and [15]), although significantminimal catalytic HMT domain affect local methylation
upregulation of luciferase activity was observed whenof histone H3K9 and the consequent repression of
equivalent amounts of ZFP-A fused to the p65 activationtarget gene expression. Furthermore, amino acid sub-
domain was used (Figure 1C). This result supports thestitutions within the HMT that ablate its catalytic activ-
chromatin-specific mode of repression expected for theity [6] effectively eliminate the ability of the ZFP fusions
ZFP-HMTs and highlights the utility of assays employingto repress transcription. Thus, H3K9 methylation is a
endogenous genes.primary signal that is sufficient for initiating a gene
repression pathway in vivo.
HMT Activity Is Necessary for Gene Repression
Results To provide evidence for the direct role of histone methyl-
transferase activity in the repression observed at the
Targeted Histone Methyltransferase Domains endogenous VEGF-A locus, we first confirmed that the
Repress Gene Expression In Vivo ZFP domain chimeras were catalytically active in vitro.
To determine whether methylation of the histone tails HA epitope-tagged ZFP-HMTs were immunoprecipi-
is causative in the process of gene repression, we linked tated from transfected cell extracts and were assayed
the catalytic HMT activities of both SUV39H1 and G9A for HMT activity. Figure 2A (Panel I) demonstrates that
to an engineered zinc-finger transcription factor (VZ  both the Suv Del 76 and G9A-ZFP chimeras have intrin-
434 [12], referred to here as ZFP-A). This engineered sic HMT activity, while control precipitations and those
DNA binding protein specifically recognizes a site at utilizing extracts transfected with the ZFP DNA binding
position 434 relative to the transcription start site of domain alone did not precipitate HMTase activity. As
the endogenous VEGF-A locus and has been shown has been previously reported, G9A is a significantly more
previously to upregulate VEGF-A transcription when potent HMT than SUV39H1 in this assay [14]. A Western
fused to the VP16 and p65 activation domains [12]. We, blot of the immunoprecipitates employed in the in vitro
and others, have employed artificial zinc-finger DNA HMTase assay shown in Figure 2A (Panel II) confirms
binding proteins to regulate a variety of endogenous that this difference in activity between the G9A and Suv
genes in vivo (see [13]). This approach therefore allows Del 76 chimeras is not a consequence of differential
expression levels.
We next asked whether the HMT activity that the ZFP1Correspondence: pgregory@sangamo.com
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fusions possess in vitro was necessary for the repres-
sion observed at the endogenous VEGF-A promoter in
vivo. To address this issue, point mutations that abolish
the HMT activity of the domains were constructed [6].
Three different amino acid substitutions were created
in the context of the ZFP-A-Suv Del 76 fusion: H324K
(mutant A), C326A (mutant B), and both mutations in
combination (mutant AB). When assayed by transient
transfection, mutations in either site alone or the combi-
nation largely abolished the transcriptional repression
function of the ZFP chimeras at the endogenous VEGF-A
gene in vivo (Figure 2B). This loss-of-repression function
was not a consequence of poor expression of the mutant
chimeras relative to wild-type (data not shown) but
rather is a direct consequence of ablation of their HMT
activity [6]. Interestingly, full-length SUV39H1 fused to
ZFP-A was unable to efficiently drive the repression of
the VEGF-A promoter, in sharp contrast to the fusions
comprising only the catalytic domain (Figure 2B). This is
perhaps due to the presence of an intact HP1 interaction
domain [16, 17], which could recruit and hence mistarget
the ZFP-SUV39H1 chimeras to regions of heterochro-
matin, thus competing with the ZFP DNA binding domain
and precluding the localization of the protein at the
VEGF-A gene.
Increased Transcriptional Repression
through Direct Recruitment of HMTs
and HDAC Activities
The precise modification state of the histone tails can
influence potential subsequent modifications. For ex-
ample, both the acetylation and phosphorylation status
of nearby residues significantly adversely affects
SUV39H1 HMT activity in vitro [6, 10], and mutation of
the HDAC Clr3 compromises global H3K9 methylation
of heterochromatic domains in S. pombe [10]. We rea-
soned that, if acetylation levels at the VEGF-A promoter
were reduced via the direct targeting of an HDAC activ-
ity, then this might increase the efficacy of the HMT
domains’ catalytic function and thus increase their re-
pression potential. To test this model, we employed a
second designed ZFP that also regulates the transcrip-
tion of the VEGF-A gene (Figure 3A and [12]). ZFP-A,
which has been used throughout this study thus far,
binds between a pair of binding sites for a second engi-
neered ZFP (VZ  42/ 530, referred to as ZFP-B).
Importantly, these two proteins have binding sites that
are separated by less than a nucleosome length, thus
ensuring that the catalytic activities recruited to either
location should act upon the same local region of chro-
matin (Figure 3A). To recruit HDAC activity to the pro-
Figure 1. ZFP-HMT Fusion Proteins Repress the Expression of the moter, we employed the v-ErbA repression domain.
Endogenous VEGF-A Gene v-ErbA is a viral relative of avian thyroid hormone recep-
(A) A schematic representation of the histone methyltransferases tor (TR) that constitutively recruits the NCoR/SMRT co-
G9A and SUV39H1 indicating the regions of each protein used as repressor complex, which utilizes associated HDAC ac-
ZFP fusions in relation to known structural features. tivities to repress transcription (see [18] and references
(B) ZFP-HMT fusions repress VEGF-A protein expression. HEK293
therein). Indeed, repression of VEGF-A by v-ErbA (Figurecells transfected with the indicated plasmids were assayed for
1) is associated with consequent deacetylation of theVEGF-A protein production by using a human VEGF-A ELISA assay
kit as described (Experimental Procedures). Transfection efficiency
was assessed in each independent experiment via the use of a
GFP expression plasmid control; in all experiments, an apparent reporter plasmid (800 ng), together with the indicated ZFP expres-
efficiency of 80%–90% GFP-positive cells was observed. sion plasmid (100 ng) and the TK renilla luciferase control reporter
(C) ZFP-HMT fusions do not repress a VEGF-A reporter plasmid. (50 ng), was assayed for luciferase activity by using the Dual-Lucifer-
HEK293 cells transfected with the VEGF-A promoter firefly luciferase ase assay 72 hr posttransfection.
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Figure 2. HMT Activity Is Required for VEGF-A
Gene Repression
(A) (Panel I) ZFP-HMT fusions are catalytically
active in vitro. Extracts from HEK293 cells
transfected with the indicated plasmids were
immunoprecipitated with either an anti-HA
epitope-tagged antibody (Anti-HA IP) or an
IgG control antibody (IgG control IP) and were
assayed for histone methyltransferase activ-
ity. (Panel II) A Western blot of extracts used
in the HMT assay (Panel I).
(B) ZFP-HMT fusions are dependent upon
their catalytic HMT activity for repression
function in vivo. HEK293 cells transfected
with the plasmids indicated were assayed for
VEGF-A mRNA by using quantitative RT-PCR
(TaqMan) after 72 hr. The VEGF-A mRNA lev-
els were normalized relative to an internal
control of GAPDH mRNA and are expressed
as this ratio. The charts represent data from
a minimum of two independent experiments,
with means and standard deviations shown.
Transfection efficiency was assessed in each
independent experiment via the use of a GFP
expression plasmid control; in all experi-
ments, an apparent efficiency of 80%–90%
GFP-positive cells was observed.
promoter-proximal histone tails (A.W.S. and P.D.G., un- histone deacetylase function, confirming the functional
link between these chromatin modifications in gene re-published data). Figure 3B shows that G9A and v-ErbA
function to repress the endogenous VEGF-A locus when pression in vivo.
fused to either of the two ZFPs. GFP fusions of the G9A
and v-ErbA functional domains, or ZFP-A constructs Targeting of HMT Domains to the Endogenous
VEGF-A Promoter Resultslacking a functional domain, fail to affect the transcrip-
tion of this locus (Figures 3B and 3C). Notably, recruit- in H3 Lysine 9 Methylation
To confirm that the ZFP-HMT-driven repression resultedment of both G9A and v-ErbA simultaneously to the
VEGF-A promoter resulted in a significant increase in from the methylation of histone H3 lysine 9 in vivo, we
performed chromatin immunoprecipitation (ChIP) as-the level of repression, beyond that of either functional
domain alone (Figure 3C and the Experimental Proce- says with antibodies specific for dimethyl-H3K9 (Up-
state Biotechnology). Precipitated DNA was then ana-dures). Importantly, no increase in repression was ob-
served by the use of combinations of ZFPs fused to lyzed with primers specific for a region adjacent to the
ZFP binding site (400) and was internally controlledthe same domain (Figure 3B). Thus, repression by HMT
domains is enhanced by the simultaneous delivery of with primers for exon 7 of the GAPDH locus. The results
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Figure 3. Coexpression of an HDAC-Recruit-
ing ZFP Enhances HMT-Mediated Repres-
sion of VEGF-A
(A) A schematic of the VEGF-A gene promoter
indicating the ZFP binding sites relative to
the transcriptional start site. Positions of the
CHIP primer pairs used in Figure 4 are also
indicated (gray boxes).
(B) HMT and v-ErbA functional domains re-
press VEGF-A transcription when linked to
either ZFP-A or ZFP-B. The indicated combi-
nations of ZFP-A, ZFP-B, and functional do-
main were assayed for VEGF-A mRNA levels
by quantitative RT-PCR (TaqMan) as de-
scribed in Figure 2B.
(C) Simultaneous targeting of both an HMT
and v-ErbA enhances repression of VEGF-A
transcription. HEK293 cells transfected with
the plasmids indicated were assayed for
VEGF-A mRNA by quantitative RT-PCR (Taq-
Man) as described in Figure 2B.
Brief Communication
2163
of this analysis are shown in Figure 4A. The level of the
H3K9 methylation signal is enriched 2- to 3-fold by
ZFP-Suv Del 76 or ZFP-G9A compared to either the
mock-transfected or the ZFP-A nonfunctional domain
control samples. No signal was obtained from control
samples prepared in the absence of the antibody (data
not shown). Importantly, transfection with the ZFP linked
to the catalytically null HMT mutant abolished the en-
richment of dimethly-H3K9, leaving only a residual signal
when compared to the control samples (Figure 4A). Con-
trol primers for exon 1 of the p16 locus (nonmethylated
and expressed in HEK293 cells) show no enrichment
upon introduction of the ZFP-HMT fusions, again dem-
onstrating that the enrichment is specific to the VEGF-A
promoter (Figure 4A). Thus, direct targeting of HMT ac-
tivity to the VEGF-A promoter via a designed zinc-finger
transcription factor results in the specific methylation
of H3K9 within nucleosomes proximal to the ZFP binding
site in vivo.
Methylation of H3K9 is postulated to act as a signal
tag for the recruitment of HP1, which, through self-asso-
ciation and interaction with SUV39H1, is thought to re-
sult in the spread of the methylation signal away from
the original methylated H3K9 residue/HP-1 binding site
[4]. To determine if this spreading occurs when the ZFP-
HMT chimeras are employed, we reanalyzed the above
samples with primer sets specific for regions increas-
ingly distant from the ZFP binding site, i.e.,1 and500,
relative to the transcription start site. The results shown
in Figures 4B and 4C demonstrate that both ZFP-G9A
and ZFP-Suv Del 76 are able to increase the H3K9 meth-
ylation signal at the VEGF-A promoter at all primer-probe
sets used. This effect is not observed at VEGF-A when
constructs without a functional domain, without a ZFP
DNA binding domain, or without catalytic HMT function
are employed (Figures 4B and 4C). Taken together, these
experiments demonstrate the ability of ZFP-HMT fu-
sions to generate a histone H3K9 methylation signal
specifically at the promoter targeted by the ZFP and
demonstrate that this methylation imprint is not re-
stricted to the immediate vicinity of the ZFP binding site.
Discussion
Histone H3 Lysine 9 Methylation Is Causative
in Gene Repression
We show here that direct targeting of catalytic HMT
activity to the promoter of an endogenous chromosomal
specific for the ZFP proximal 400 region. Enrichment was quanti-
fied by RT-PCR. Results are expressed as the fold increase of the
ratio to the GAPDH control relative to the results for nontransfected
cells, the value of which is arbitrarily set to 1. The same samples
were analyzed with primers specific to the p16 locus as a second
internal control (light gray bars). No enrichment was observed with
preimmune serum (data not shown).
(B) ZFP-G9A induces the spread of H3K9 methylation across the
VEGF-A promoter in vivo. HEK293 cells transfected with the plas-
mids indicated were assayed for methylation of H3K9 by ChIP with
primers specific for the regions centered on 400, 1, and 500.
Samples were treated as in Figure 4A.
Figure 4. ZFP-HMT Fusions Methylate H3K9 Promoter Nucleo- (C) ZFP-Suv Del 76 is dependent upon its catalytic HMT activity for
somes at the VEGF-A Locus spreading H3K9 methylation across the VEGF-A promoter in vivo.
(A) ZFP-HMT fusions require catalytic activity to methylate H3K9 at HEK293 cells transfected with the plasmids indicated were assayed
the VEGF-A promoter. HEK293 cells transfected with the indicated for H3K9 by ChIP with primers specific for the regions centered
plasmids were assayed for H3K9 methylation by ChIP with primers on 400, 1, and 500. Samples were treated as in Figure 4A.
Current Biology
2164
gene via ZFP fusions results in the local methylation of gether, these data support the establishment of a his-
tone methylation signal as causative in this repressionH3K9 in chromatin and parallel transcriptional repres-
sion of the specified gene. Point mutations within key pathway.
residues of the catalytic core of SUV39H1, which result
in the loss of its catalytic activity [6], greatly reduce the ZFP-Driven Control of Endogenous Genes
We show here how novel ZFP transcription factors canZFP fusions’ ability to drive H3K9 methylation and the
consequent transcriptional repression of the target be engineered to direct functional domains and/or cata-
lytic activities to precise locations within the human ge-gene. These data present the first direct demonstration
of a causal role for H3K9 methylation in endogenous nome to regulate endogenous gene expression. In con-
trast to a transient reporter gene assay, this uniquechromosomal gene repression in vivo. Furthermore, the
establishment of an H3K9 methylation pattern is shown capability allows the study of the molecular processes
involved in both transcriptional regulation and in theto be a primary signal that is sufficient for initiating a
gene repression pathway. Indeed, HMT-driven tran- modulation of chromatin structure directly on endoge-
nous genes, i.e., within their native chromatin architec-scriptional repression is likely to be conserved through-
out all higher eukaryotes, since we observed that tar- ture. Furthermore, the direct targeting of enzymatic ac-
tivities such as the H3K9 HMTs described here, able togeting these activities to the IGF2 and H19 genes
achieved the transcriptional repression of these loci mark a region of chromatin for transcriptional silencing,
provides both a powerful research tool and potential(data not shown) and that the Arabadopsis homolog of
SUV39H1 was able to functionally repress the human therapeutic avenue in the study and treatment of human
disease.VEGF-A gene when fused to ZFP-A (A.W.S. and G. Li,
unpublished data).
Experimental ProceduresIn keeping with the in vitro substrate specificity of G9A
and SUV39H1, we demonstrate that ZFP-HMT-mediated
Cell Culture and Transient Transfections
repression is enhanced when coupled with histone de- HEK293 cells were grown in Dulbecco’s modified Eagle’s medium
acetylase recruitment, via the use of a second HDAC- supplemented with 10% fetal bovine serum in a 5% CO2 incubator
at 37C. For transfections, HEK293 cells were plated in 12-well platesrecruiting ZFP targeted within close proximity of the
at a density of 250,000 cells/well and were transfected 1 day laterfirst. These data support genetic studies suggesting a
with Lipofectamine 2000 reagent (GIBCO-BRL), according to manu-mechanistic link between these two histone-modifying
facturer’s recommendations, by using 9 l Lipofectamine 2000 re-activities and imply a functional role for the close associ-
agent and 1.5 g ZFP plasmid DNA per well. The medium was
ation between HDAC and HMT activities in natural core- removed and replaced with fresh medium 6–12 hr after transfection.
pressor complexes, such as those associated with the For the coexpression experiments in Figure 3, to compensate for
the difference in the apparent Kd of each ZFP for its binding siteaction of KRAB repression domain [7].
[19], 250 ng ZFP-A constructs were combined with 1.25 g ZFP-B
constructs throughout. Transfection efficiency was assessed in
each independent experiment via the use of a GFP expression plas-Role of HP1 and the Chromodomain
mid control; in all experiments, an apparent efficiency of 80%–90%in Gene Repression
GFP-positive cells was observed.
Methylated H3K9 is specifically recognized by HP1 via
its chromodomain [4, 5]. In the ChIP experiments (Fig- Immunoprecipitations and Histone Methyltransferase
Activity Assaysures 4B and 4C), we observed an increase in H3K9
Whole-cell lysates were precleared with a 40 l bed volume ofmethylation not only in the direct vicinity of the ZFP
Protein G Agarose beads for 30 min at 4C with agitation. The lysatesbinding site, but also at the start site of transcription,
were spun at 1000 rpm for 1 min, and the clarified lysate was re-500 bp upstream, and indeed at 500 relative to the
moved and used in an immunoprecipitation with 5 l anti-HA epi-
transcriptional start site, i.e., 1000 bp away from the tope-tagged antibody (sc-7392 Santa Cruz) or an IgG control anti-
ZFP binding site. This spreading of histone methylation body and was incubated at 4C for 2 hr with agitation. A 20 l
bed volume of Protein G Agarose beads was then added, and theinto the promoter region occurs with both G9A and
samples were incubated for an additional hour at 4C with agitation.SUV39H1 ZFP fusion proteins, even though the amino-
Samples were spun down (1000 rpm for 1 min) and washed threeterminal region of the SUV39H1, which has been associ-
times in wash buffer (20 mM HEPES [pH 7.9], 75 mM KCl, 2.5 mMated with HP1 interaction, was deleted [16]. Indeed, the
MgCl2, 1 mM DTT, 0.5 mM PMSF). Samples were then resuspendedinability of the catalytically inactive mutants of Suv Del in HMT assay buffer (50 mM TRIS [pH 8.0], 20 mM KCl, 250 mM
76 to repress transcription as ZFP chimeras demon- sucrose, 10 mM MgCl2, 1 mM DTT) containing 10 g bulk histones
(Sigma) and 1 l S-adenosyl-(methyl-3H)-L-methionine (80 Ci/mM;strates the dependence of their repression activity on
PerkinElmer Life Sciences) as a methyl donor. Samples were incu-H3K9 methylation activity. These data are thus most
bated for 1 hr at 30C, and reactions were terminated by the additionconsistent with the ZFP-dependent local methylation of
of 2 SDS-PAGE sample buffer. Protein samples were resolved onH3K9 acting as a nucleation point for HP1 recruitment.
a 10%–20% SDS-PAGE gradient gel (Biorad), which was then
Subsequent spreading of the H3K9 imprint via HP1 bind- treated with Amplify (Amersham Pharmacia Biotech), dried down,
ing [4] coupled with recruitment of additional methyl- and exposed to X-ray film.
transferase activity (mediated at least in part through
RT-PCR Cloning of SUV39H1 and G9Athe interaction of HP1 with SUV39H1 [17]) thus recruits
cDNA was prepared and pooled from RNA derived from HEK293,additional HMT activity to ZFP distal locations. Indeed,
MCF-7, and U2OS cell lines by using the thermoscript real-timewhen catalytically null mutants were employed, both a
quantitative PCR (RT-PCR) system (GIBCO-BRL) according to the
stark reduction in histone methylation proximal to the manufacturer’s recommendations. The DNA encoding the human
ZFP binding site and an abolition of the spread of meth- G9A catalytic domain and full-length SUV39H1 were generated via
PCR from the cDNA pool by using Platinum Taq High Fidelity DNAylation into the promoter were observed. Taken to-
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polymerase (Invitrogen) with the indicated primers. Constructs gen- dimethyl-histone H3K9 (Upstate Biotechnology) with agitation.
Salmon sperm DNA/Protein A Agarose slurry was added and incu-erated via PCR were sequence confirmed. SUV39H1 deletions 76
and 149 were generated via PCR by using full-length SUV39H1 as bated for 1 hr at 4C with agitation. The antibody-agarose complex
was centrifuged and washed five times, and the immunoprecipitatedtemplate. All HMT constructs were subcloned into the ZFP plasmid
backbone by using engineered 5 BamH1 and 3 XhoI restriction fraction was eluted. The crosslinking was reversed by incubation
at 65C for 4 hr in the presence of 200 mM NaCl. The DNA wassites.
The following primers were used (all primers are listed in the 5 recovered by phenol/chloroform extraction and precipitated, and
the abundance of specific sequences was quantitated by using RT-to 3 direction): RT-PCR full-length hSUV39H1 forward primer: CGG
ATCCCCGTGGGGAAAGATGGCGG, reverse primer: CGCGGCCGC PCR (TaqMan) as described above, omitting the reverse transcrip-
tion reaction step. Relative abundances of the various VEGF-A geno-GACAGGAGGGCAGCAGTGGG; Suv39H1 Del 76 forward primer:
CAGGATCCCCACGGCAGAATCTCAA; Suv39H1 Del 149 forward mic primers were calculated relative to an internal GAPDH genomic
probe set.primer: CAGGATCCGAGAATGAGGTGGACCTG; Reverse Suv39H1
primer: TACTCGAGCTAGAAGAGGTATTTGCGGCAGGACTC; G9A The following primers were used (all primers are listed in the 5
to 3 direction): GAPDH genomic forward primer: ACATCAAGAAGGcat domain forward primer: GAGGATCCGGCAGCGCCGCCATCGC
CGAA; G9A cat domain reverse primer: GACTCGAGTCATGTGTT TGGTGAAG, reverse primer AGCTTGACAAAGTGGTCGTTG; VEGF
400 region forward primer: CAGCGAAAGCGACAGGGG, reverseGACAGGGGGCAGG.
primer GTCAGCTGCGGGATCCC; VEGF –500 region forward primer:
GGCCACCACAGGGAAGCT, reverse primer: ACACAGACACACACSite-Directed Mutagenesis of Suv39H1 Del 76
GTCCTCACT; VEGF start site (1 region) forward primer: AGGATCSite-directed mutagenesis was performed by using the quick-
GCGGAGGCTTG, reverse primer: CGACAGAGCGCTGGTGCTA; p16change site-directed mutagenesis kit (Stratagene) according to the
exon 1 forward primer: TCTGGAGGACGAAGTTTGCA, reversemanufacturer’s recommendations.
primer: CCAGGAAGCCTCCCCTTTT.The following primers were used (all primers are listed in the 5
to 3 direction): mutant A forward primer: CTCCCACTTTGTCAA
CAAAAGTTGTGACCCCAACCTGCAG, mutant A reverse primer: CTG Acknowledgments
CAGGTTGGGGTCAACAACTTTTGTTGACAAAGTGGGAG, mutant B
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